logo

For the Inventor, By the Inventor

Carlsbad, CA, United States of America

Andrew Tochterman

This inventor holds 15 USPTO granted patents and 10 published patent applications and 1 EPO patent, primarily in Percutaneous Coronary Intervention. Top assignees: Philips Image Guided Therapy Corporation, Koninklijke Philips Corporation N.v., Volcano Corporation. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew Tochterman. Retrieved from https://idiyas.com/inventor/andrew-tochterman-4wev3pah

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 15 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.2

ph-index = 8

Forward Citations = 116(Granted Patents)


Company Filing History:

goldMedal13 out of 258 
 
Philips Image Guided Therapy Corporation
 patents
silverMedal1 out of 21,919 
 
Koninklijke Philips Corporation N.v.
 patents
bronzeMedal1 out of 284 
 
Volcano Corporation
 patents

Years Active: 2020-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
PCI Planning Interface
Vessel Assessment
Intravascular Lesions
Pressure Data
Sensing Components
Display Screens
Assessment Devices
Automated Classification
15 patents (USPTO):Explore Patents
1. 12237067 - Percutaneous coronary intervention (PCI) planning interface and associated devices, systems, and methods (2025-02-25),
2. 12178619 - Percutaneous coronary intervention (PCI) planning interface with pressure data and vessel data and associated devices, systems, and methods (2024-12-31),
3. 12115007 - Devices, systems, and methods and associated display screens for assessment of vessels with multiple sensing components (2024-10-15),
4. 12087427 - Percutaneous coronary intervention (PCI) planning interface and associated devices, systems, and methods (2024-09-10),
5. 11779286 - Percutaneous coronary intervention (PCI) planning interface with pressure data and vessel data and associated devices, systems, and methods (2023-10-10),
6. 11688502 - Percutaneous coronary intervention (PCI) planning interface and associated devices, systems, and methods (2023-06-27),
7. 11672434 - Devices, systems, and methods for assessment of vessels (2023-06-13),
8. 11205507 - Percutaneous coronary intervention (PCI) planning interface and associated devices, systems, and methods (2021-12-21),
9. 11160513 - Percutaneous coronary intervention (PCI) planning interface with pressure data and vessel data and associated devices, systems, and methods (2021-11-02),
10. 11123019 - Automated identification and classification of intravascular lesions (2021-09-21),
11. 10993628 - Devices, systems, and methods for vessel assessment (2021-05-04),
12. 10849511 - Devices, systems, and methods for assessment of vessels (2020-12-01),
13. 10667775 - Percutaneous coronary intervention (PCI) planning interface and associated devices, systems, and methods (2020-06-02),
14. 10568585 - Percutaneous coronary intervention (PCI) planning interface with pressure data and vessel data and associated devices, systems, and methods (2020-02-25),
15. 10531841 - Devices, systems, and methods and associated display screens for assessment of vessels with multiple sensing components (2020-01-14),

Title: **Andrew Tochterman: Innovator in Coronary Intervention Technology**

Introduction

Andrew Tochterman is a prominent inventor based in Carlsbad, California, known for his innovative contributions to medical technology, particularly in the field of cardiac procedures. With a remarkable portfolio of 15 patents, Tochterman's work focuses on enhancing the effectiveness of percutaneous coronary interventions (PCI), a critical area in cardiac care.

Latest Patents

Tochterman’s recent patents include groundbreaking technologies aimed at optimizing PCI planning. One notable invention is a method for evaluating a patient’s vessel, which incorporates a visualization interface based on pressure measurements. This method involves a display that shows a detailed visualization while allowing users to simulate therapeutic procedures interactively. Another significant patent involves devices and systems directed to evaluating a patient’s vessel, enhancing the understanding of pressure ratios through user-friendly visual representations. These innovations aim to improve patient outcomes by providing more precise procedural planning.

Career Highlights

Throughout his career, Andrew Tochterman has worked with leading companies in the medical technology sector, including Philips Image Guided Therapy Corporation and Volcano Corporation. His roles have significantly advanced the field, allowing for the development and integration of state-of-the-art technologies that improve coronary intervention strategies.

Collaborations

Tochterman has collaborated with esteemed professionals such as David M. Anderson and Fergus Merritt. Working alongside these talented individuals, he has contributed to vital research and development projects that have pushed the boundaries of what is possible in cardiac care.

Conclusion

Andrew Tochterman exemplifies the spirit of innovation within the medical technology landscape. His dedication to improving percutaneous coronary interventions through his patented inventions has not only marked significant advancements in the field but also enhanced patient care and procedural efficacy. Through his work, Tochterman continues to inspire future innovations in medical technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…